Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Acta Pharmaceutica Sinica ; (12): 1471-1474, 2013.
Article Dans Chinois | WPRIM | ID: wpr-298056

Résumé

In order to study the excretion of genistein (GEN) capsule, an estrogen drugs, in human, 30 healthy volunteers were selected and orally administered 50, 100, and 300 mg genistein in an parallel study. Genistein were determined in urine by LC-MS/MS and glucuronidated genistein (GENG) were indirectly determined with enzymatic hydrolysis in urine by LC-MS/MS, and the pharmacokinetic parameters were analyzed by DAS software (ver 2.0). The result showed that the concentrations of genistein in human urine were less than 1% of the GENG, and the cumulative excretion of GEN in 48 h were 0.037, 0.134, and 0.142 mg, separately, and the urinary excretion percentage were only 0.07%, 0.13%, and 0.05%, separately. But the cumulative excretion of GENG in 48 h was 5.3, 13.8, and 15.4 mg, separately, and the urinary excretion percentage were 10.6%, 13.8%, and 5.1%, separately, and the max urinary excretive rate was 0.4, 1.0, and 1.4 mg x h(-1), separately (tmax were 6 h). Studies showed that part of drug excreted through kidney in a form of GENG in human, and the cumulative urinary excretion and the maximum excretion rate of GENG showed a proportional increase conditioned with the dose in the range of 50-100 mg, but showed non-linear increase feature in 300 mg.


Sujets)
Adulte , Femelle , Humains , Mâle , Jeune adulte , Administration par voie orale , Anticarcinogènes , Pharmacocinétique , Urine , Chromatographie en phase liquide , Génistéine , Pharmacocinétique , Urine , Glucuronides , Urine , Volontaires sains , Phyto-oestrogènes , Pharmacocinétique , Urine , Spectrométrie de masse en tandem
2.
Acta Pharmaceutica Sinica ; (12): 365-368, 2005.
Article Dans Chinois | WPRIM | ID: wpr-353494

Résumé

<p><b>AIM</b>To study the pharmacokinetics of ginsenosides Rg1 and Re after iv infusion of Shenmai injection in human.</p><p><b>METHODS</b>Ginsenosides Rg1 and Re in plasma were determined by LC/MS/MS and the pharmacokinetic parameters were calculated.</p><p><b>RESULTS</b>The linear regressive curves were obtained in the range of 1.023-1023 microg x L(-1) for Rg1 and 1.05-1050 microg x L(-1) for Re. Recoveries using the method of Rg1 and Re were 99%-105% and 99%-104%, respectively. The within-day and between-day RSDs were less than 15%. After iv infusion of Shenmai injection to volunteers, the concentration-time curves of Rg1 and Re fitted to the two-compartment model, T1/2alpha were 0.28 h and 0.10 h, T1/2beta were 2.1 h and 1.2 h, respectively.</p><p><b>CONCLUSION</b>The method is specific, simple, sensitive and suitable for the measurement of plasma Rg1 and Re concentrations. The distribution and elimination of Rg1 and Re were rapid after iv infusion of Shenmai injection in volunteers, the pharmacokinetic characteristics were fitted with the two-compartment model.</p>


Sujets)
Femelle , Humains , Mâle , Aire sous la courbe , Chromatographie en phase liquide , Association médicamenteuse , Médicaments issus de plantes chinoises , Pharmacocinétique , Ginsénosides , Sang , Pharmacocinétique , Perfusions veineuses , Ophiopogon , Chimie , Panax , Chimie , Plantes médicinales , Chimie , Spectrométrie de masse ESI
SÉLECTION CITATIONS
Détails de la recherche